Drug Shortage Report for SHINGRIX
| Report ID | 59145 |
| Drug Identification Number | 02468425 |
| Brand name | SHINGRIX |
| Common or Proper name | Herpes Zoster vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
| Strength(s) | 50MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 10's |
| ATC code | J07BK |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-08-24 |
| Estimated end date | |
| Actual end date | 2020-06-17 |
| Shortage status | Resolved |
| Updated date | 2020-06-18 |
| Company comments | High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.